Preprint Article Version 2 Preserved in Portico This version is not peer-reviewed

Clinical Experience with the Fifth-Generation of a Breast Implant with a Smooth, Fine Surface from a Korean Manufacturer in Asian Women

Version 1 : Received: 17 June 2021 / Approved: 24 June 2021 / Online: 24 June 2021 (10:22:51 CEST)
Version 2 : Received: 24 July 2021 / Approved: 28 July 2021 / Online: 28 July 2021 (16:56:31 CEST)

A peer-reviewed article of this Preprint also exists.

Journal reference: Journal of Biosciences and Medicines 2022, 10
DOI: 10.4236/jbm.2022.106012


Background In this study, we describe our clinical experience with the fifth-generation of a breast implant with a smooth, fine surface from a Korean manufacturer (BellaGelÒ SmoothFine; HansBiomed Co. Ltd., Seoul, Korea) in Asian women. Methods We analyzed 223 women (mean age=35.28±9.45 years and mean follow-up period=12.03±2.48 months), comprising 118 bilateral cases and 109 unilateral ones, who received breast augmentation using the BellaGelÒ SmoothFine at our hospital between June 4, 2018 and February 28, 2019. For safety assessment, we analyzed frequencies of postoperative complications and overall survival of the BellaGelÒ SmoothFine. Results Postoperatively, complications (12 cases, 5.38%) include asymmetry (3 cases, 1.35%), hematoma (2 cases, 0.90%), hypertrophic scars (2 cases, 0.90%), wound disruption (2 cases, 0.90%), rippling (1 case, 0.45%), capsular contracture (1 case, 0.45%), stretch deformities with skin excess (1 case, 0.45%). In addition, time-to-events were calculated as 10.94±0.64 months (95% CI 9.69-12.19) and the survival rate reached 0.290±0.168 (95% CI 0.094-0.901) at 12 months postoperatively. Conclusions Here, we describe our clinical experience with the BellaGelÒ SmoothFine. Our results are of significance in that this is the first report about the fifth-generation of a breast implant with a smooth, fine surface from a Korean manufacturer in Asian women.


Clinical Study; Retrospective Studies; Surgical Procedures, Operative; Postoperative Period; Follow-Up Studies.



Comments (1)

Comment 1
Received: 28 July 2021
Commenter: Robert Kim
Commenter's Conflict of Interests: Author
Comment: Some unnecessary texts were deleted. Results of Kaplan-Meier hazards analysis were described.
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 1
Metrics 0

Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.